View Author
scopus: 6602593030

Peer, M.A. van

(Maartje van Peer)


virus infection challenge antibody vaccinated autologou siebelink vaccine vaccination immunodeficiency immunodeficiency virus cats vaccinated enhancement envelope protein study envelope protein assay immunode ficiency virus osterhau vaccinated cats immunodeficiency virus infection antigen virol ficiency immunode response hosie control cats protection fiv-infected immunology control elisa plasma clone karla neutralization journal challenge infection serum glycoprotein titer cat nos rimmelzwaan activation immunopathology huisman 353±365 pedersen clone fiv -19k proviral dna autologous fiv-infected pbmc antigen elisa virology fiv antigen fi xed autologous yamamoto number peptide autologous fiv antibody response virus neutralizing antibodies receptor viraemia post-challenge 1996. puri fied immunoglobulins immunol timepoint t-cell neutralizing willett di fferences fiv 19k replication model titre lentiviru matteucci




2 Most Recent Publications

Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challenge infection. (Article)
Karlas, J.A. Siebelink, C.H.J. Peer, M.A. van Huisman, W. Cuisinier, A.M. Rimmelzwaan, G.F. Osterhaus, A.D.M.E.
1999-01-01
Accelerated viraemia in cats vaccinated with fixed autologous FIV-infected cells. Abstract 2nd International Feline Immunology Workshop, 31 July-3 August 1997, Davis, USA. (Article)
Karlas, J.A. Siebelink, C.H.J. Peer, M.A. van Huisman, W. Rimmelzwaan, G.F. Osterhaus, A.D.M.E.
1998-10-23